SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Vol. 2. Geneva, Switzerland: WHO, 1983.
  • 2
    Hall MH, Danielian P, Lamont RF. The importance of preterm birth. In: ElderMG, LamontRF, RomeroR, editors. Preterm Labor. New York, NY: Churchill Livingstone; 1997. pp. 128.
  • 3
    Steer P, Flint C. Preterm labour and premature rupture of membranes. BMJ 1999;318:105962.
  • 4
    Maresh M. The obstetric management of preterm labour. Curr Obstet Gynaecol 1992;2:199206.
  • 5
    Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:1125.
  • 6
    Lamont RF, Dunlop PD, Crowley P, Levene MI, Elder MG. Comparative mortality and morbidity of infants transferred in utero or postnatally. J Perinat Med 1983;11:2003.
  • 7
    Keirse MJNC. Betamimetic tocolytics in preterm labour. In: KeirseMJNC, RenfrewMJ, NeilsonJP, CrowtherC, editors. Pregnancy and Childbirth Module. The Cochrane Pregnancy and Childbirth Database. The Cochrane Collaboration. Oxford: Update Software, 1995.
  • 8
    Royal College of Obstetricians and Gynaecologists. Tocolytic Drugs for Women in Preterm Labour. Clinical Guideline No. 1(B), 2002. [http://www.rcog.org.uk/index.asp?PageID=536]. Accessed 18 October 2006.
  • 9
    Oei SG, Mol BW, De Kleine MJK, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis. Acta Obstet Gynecol Scand 1999;78:7838.
  • 10
    King J, Flenady V, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour: a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol 2003;43:1928.
  • 11
    Lamont RF, Khan KS, Beattie B, Cabero Roura L, Di Renzo GC, Dudenhausen J, et al. The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J Perinat Med 2005;33:28795.
  • 12
    Bal L, Thierry S, Brocas E, Adam M, Van de Louw A, Tenaillon A. Pulmonary edema induced by calcium-channel blockade for tocolysis. Anesth Analg 2004;99:91011.
  • 13
    Hodges R, Barkehall-Thomas A, Tippett C. Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG 2004;111:3801.
  • 14
    Oei SG, Oei SK, Brolmann HA. Myocardial infarction during nifedipine therapy for preterm labour. N Engl J Med 1999;340:154.
  • 15
    Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, Provost-Helou N, Ducloy-Bouthors AS, Puech F, et al. Acute pulmonary oedema during nicardipine therapy for preterm labour, report of 5 cases. Eur J Obstet Gynecol Reprod Biol 2004;113:989.
  • 16
    Verhaert D, Van Acker R. Acute myocardial infarction during pregnancy. Acta Cardiol 2004;59:3319.
  • 17
    Van Veen AJ, Pelinck MJ, Van Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG 2005;112:50910.
  • 18
    Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:117383.
  • 19
    Moutquin J-M, the worldwide atosiban versus beta-agonists survey group. Double-blind, randomised controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety survey. Am J Obstet Gynecol 2000;182:11919.
  • 20
    Cabrol D, The French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:17785.
  • 21
    Maršál K, the worldwide atosiban versus beta-agonists survey group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. Acta Obstet Gynecol Scand 2001;80:41322.
  • 22
    Moutquin J-M, the worldwide atosiban versus beta-agonists survey group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001;108:13342.
  • 23
    Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynaecol Obstet 2005;91:1014.
  • 24
    Husslein P, Quartarolo JP. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Int J Clin Pract 2003;57:1217. To be replaced with Acta Ob Gyn in press if accepted for publication.
  • 25
    Husslein P, The TREASURE study group. Clinical practice evaluation of atosiban in preterm labour management in six European countries. COGI, Athens, Greece, 2005.
  • 26
    Fuentes A, Williams M. Cervical assessment. Clin Obstet Gynecol 1995;38:22431.
  • 27
    Swamy GK, Simhan HN, Gammill HS, Heine RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005;50:8516.